Mark W. Begor - 28 Jul 2025 Form 4 Insider Report for EQUIFAX INC (EFX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
30 Jul 2025, 16:20:27 UTC
Prior SEC filing
23 May 2025
Next SEC filing
29 Oct 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/Lisa Stockard as Attorney-in-Fact

Key filing fact

Mark W. Begor filed Form 4 for EQUIFAX INC (EFX) on 30 Jul 2025.

Key facts

  • This page summarizes Mark W. Begor's Form 4 filing for EQUIFAX INC (EFX).
  • 7 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 30 Jul 2025, 16:20.

Change

  • Previous filing in this sequence was filed on 23 May 2025.
  • Current net transaction value: -$6,313,351.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001335111 Primary reporting owner

Begor Mark W

Relationship
CEO, Director
Address
1550 PEACHTREE STREET, N.W., ATLANTA
Signature
/s/Lisa Stockard as Attorney-in-Fact
Signature date
30 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EFX transaction

Common Stock

Options Exercise

Transaction value
$5,352,662
Shares
+27,960
Change %
+17%
Price
$191.44
Shares after
191,136
Date
28 Jul 2025
Ownership
Direct
EFX transaction

Common Stock

Sale

Transaction value
$89,161
Shares
-364
Change %
-0.19%
Price
$244.95
Shares after
190,772
Date
28 Jul 2025
Ownership
Direct
Footnotes
F1, F2, F3
EFX transaction

Common Stock

Sale

Transaction value
$202,684
Shares
-831
Change %
-0.44%
Price
$243.90
Shares after
189,941
Date
28 Jul 2025
Ownership
Direct
Footnotes
F1, F3, F4
EFX transaction

Common Stock

Sale

Transaction value
$2,304,935
Shares
-9,497
Change %
-5%
Price
$242.70
Shares after
180,444
Date
28 Jul 2025
Ownership
Direct
Footnotes
F1, F3, F5
EFX transaction

Common Stock

Sale

Transaction value
$4,288,620
Shares
-17,731
Change %
-9.8%
Price
$241.87
Shares after
162,713
Date
28 Jul 2025
Ownership
Direct
Footnotes
F1, F3, F6
EFX transaction

Common Stock

Sale

Transaction value
$4,780,614
Shares
-19,841
Change %
-12%
Price
$240.95
Shares after
142,872
Date
28 Jul 2025
Ownership
Direct
Footnotes
F1, F3, F7
EFX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
10,500
Date
28 Jul 2025
Ownership
2-yr 2025 GRAT
EFX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
9,525
Date
28 Jul 2025
Ownership
2-yr Feb 2024 GRAT
EFX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
11,380
Date
28 Jul 2025
Ownership
2-yr Jul 2024 GRAT
EFX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
43,431
Date
28 Jul 2025
Ownership
2-yr Jun 2025 GRAT
EFX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
12,333
Date
28 Jul 2025
Ownership
2-yr May 2025 GRAT
EFX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
16,287
Date
28 Jul 2025
Ownership
3-yr Jul 2024 GRAT

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EFX transaction Derivative

Stock Option/Right to Buy

Options Exercise

Transaction value
$0
Shares
-27,960
Change %
-50%
Price
$0.000000
Shares after
27,959
Date
28 Jul 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
27,960
Exercise price
$191.44
Footnotes
F8
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 8 footnotes

Footnote F1

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/14/2024.

Footnote F2

The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $244.72 to $245.33, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

Footnote F3

Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 199 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan.

Footnote F4

The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $243.47 to $244.44, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

Footnote F5

The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $242.41 to $243.17, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

Footnote F6

The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $241.41 to $242.40, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

Footnote F7

The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $240.40 to $241.39, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

Footnote F8

The option vested in three equal annual increments beginning 2/21/2021.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .